Gastroenterology and Liver Services, Concord Repatriation General Hospital, Sydney, Australia.
Inflamm Bowel Dis. 2013 Aug;19(9):1880-8. doi: 10.1097/MIB.0b013e31829080a8.
Data from the northern hemisphere suggest that patients with ulcerative colitis (UC) have similar survival to the general population, whereas mortality in Crohn's disease (CD) is increased by up to 50%. There is a paucity of data from the southern hemisphere, especially in Australia.
A prevalence cohort (1977-1992) of patients with inflammatory bowel disease (IBD) diagnosed after 1970 was studied. Survival status data and causes of death up to December 2010 were extracted from the National Death Index. Relative survival analysis was carried out separately for men and women.
Of 816 cases (384 men, 432 women; 373 CD, 401 UC, 42 indeterminate colitis), 211 (25.9%) had died by December 2010. Median follow-up was 22.2 years. Relative survival of all patients with IBD was not significantly different from the general population at 10, 20, and 30 years of follow-up. Separate analyses of survival in CD and UC also showed no differences from the general population. There was no difference in survival between patients diagnosed earlier (1971-1979) or later (1980-1992). At least 17% of the deaths were caused by IBD. Fatal cholangiocarcinomas were more common in IBD (P < 0.001), and fatal colorectal cancers more common in UC (P = 0.047).
In Australia, IBD patient survival is similar to the general population. In contrast to data from Europe and North America, survival in CD is not diminished in Australia. IBD caused direct mortality in 17%, especially as biliary and colorectal cancers are significant causes of death.
来自北半球的数据表明,溃疡性结肠炎(UC)患者的生存率与普通人群相似,而克罗恩病(CD)患者的死亡率增加了 50%。来自南半球的数据,特别是来自澳大利亚的数据非常有限。
研究了一组 1977 年至 1992 年间确诊的炎症性肠病(IBD)患者的患病率队列(1970 年后确诊)。从国家死亡索引中提取了截至 2010 年 12 月的生存状态数据和死因。对男性和女性分别进行了相对生存率分析。
在 816 例患者(384 名男性,432 名女性;373 例 CD,401 例 UC,42 例不确定结肠炎)中,211 例(25.9%)于 2010 年 12 月前死亡。中位随访时间为 22.2 年。所有 IBD 患者的相对生存率在 10、20 和 30 年的随访中与普通人群无显著差异。CD 和 UC 患者的生存情况单独分析也与普通人群无差异。早期(1971-1979 年)或晚期(1980-1992 年)诊断的患者之间生存无差异。至少有 17%的死亡是由 IBD 引起的。IBD 患者中致命性胆管癌更为常见(P<0.001),UC 患者中致命性结直肠癌更为常见(P=0.047)。
在澳大利亚,IBD 患者的生存率与普通人群相似。与欧洲和北美的数据相反,CD 的生存率在澳大利亚并没有降低。IBD 直接导致了 17%的死亡,特别是胆管癌和结直肠癌是重要的死亡原因。